113 related articles for article (PubMed ID: 35389570)
1. Spastic Paraplegia 20 and Serine/Threonine Protein Kinase 31 Expression for the Detection of Colorectal Cancer.
Hassan NA; Idriss NK; Gaber N; Ibrahim A; Tawfeek MA; Mossad E; Mosa AA; Ahmed EH; Sayed SA; Ahmed HA; Mohamed AAM
Cell Physiol Biochem; 2022 Apr; 56(2):138-149. PubMed ID: 35389570
[TBL] [Abstract][Full Text] [Related]
2. STK31 as novel biomarker of metastatic potential and tumorigenicity of colorectal cancer.
Zhong L; Liu J; Hu Y; Wang W; Xu F; Xu W; Han J; Biskup E
Oncotarget; 2017 Apr; 8(15):24354-24361. PubMed ID: 28412729
[TBL] [Abstract][Full Text] [Related]
3. Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps.
Watany MM; Elmashad NM; Badawi R; Hawash N
Clin Chim Acta; 2018 Aug; 483():151-155. PubMed ID: 29715435
[TBL] [Abstract][Full Text] [Related]
4. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
[TBL] [Abstract][Full Text] [Related]
5. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis.
Lind GE; Raiborg C; Danielsen SA; Rognum TO; Thiis-Evensen E; Hoff G; Nesbakken A; Stenmark H; Lothe RA
Oncogene; 2011 Sep; 30(37):3967-78. PubMed ID: 21499309
[TBL] [Abstract][Full Text] [Related]
6. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
7.
Bae DH; Kim HJ; Yoon BH; Park JL; Kim M; Kim SK; Kim SY; Lee SI; Song KS; Kim YS
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649810
[TBL] [Abstract][Full Text] [Related]
8. STK31 is a cell-cycle regulated protein that contributes to the tumorigenicity of epithelial cancer cells.
Kuo PL; Huang YL; Hsieh CC; Lee JC; Lin BW; Hung LY
PLoS One; 2014; 9(3):e93303. PubMed ID: 24667656
[TBL] [Abstract][Full Text] [Related]
9. Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method.
Rezvani N; Alibakhshi R; Vaisi-Raygani A; Bashiri H; Saidijam M
Oncol Lett; 2017 May; 13(5):3277-3284. PubMed ID: 28521434
[TBL] [Abstract][Full Text] [Related]
10. Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival.
Yuan W; Gao H; Wang G; Miao Y; Jiang K; Zhang K; Wu J
Cancer Med; 2020 Dec; 9(24):9632-9640. PubMed ID: 33128354
[TBL] [Abstract][Full Text] [Related]
11. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
Yokoe T; Tanaka F; Mimori K; Inoue H; Ohmachi T; Kusunoki M; Mori M
Cancer Res; 2008 Feb; 68(4):1074-82. PubMed ID: 18281482
[TBL] [Abstract][Full Text] [Related]
12. Methylation Heterogeneity and Gene Expression of SPG20 in Solid Tumors.
Cusenza VY; Braglia L; Frazzi R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627246
[TBL] [Abstract][Full Text] [Related]
13. STK31 maintains the undifferentiated state of colon cancer cells.
Fok KL; Chung CM; Yi SQ; Jiang X; Sun X; Chen H; Chen YC; Kung HF; Tao Q; Diao R; Chan H; Zhang XH; Chung YW; Cai Z; Chang Chan H
Carcinogenesis; 2012 Nov; 33(11):2044-53. PubMed ID: 22828137
[TBL] [Abstract][Full Text] [Related]
14. Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer.
Zhang H; Song YC; Dang CX
Int J Med Sci; 2013; 10(3):230-4. PubMed ID: 23372428
[TBL] [Abstract][Full Text] [Related]
15. STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/β‑catenin pathway and feedback regulation by c‑myc.
Xiong J; Xing S; Dong Z; Niu L; Xu Q; Liu P; Yang P
Oncol Rep; 2020 Feb; 43(2):395-404. PubMed ID: 31894338
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.
Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N
Gene; 2019 Dec; 721():144097. PubMed ID: 31493507
[TBL] [Abstract][Full Text] [Related]
18. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
19. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer.
Li R; Liu B; Yin H; Sun W; Yin J; Su Q
J Mol Histol; 2013 Apr; 44(2):183-9. PubMed ID: 23108908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
